Cooper Companies (The)COOEarnings & Financial Report
The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision (CVI) which manufactures contact lenses, and CooperSurgical (CSI), which manufactures medical devices and fertility and genomic products for the women's healthcare market.
COO Q4 FY2025 Key Financial Metrics
Revenue
$1.1B
Gross Profit
$650.8M
Operating Profit
$140.4M
Net Profit
$84.6M
Gross Margin
61.1%
Operating Margin
13.2%
Net Margin
7.9%
YoY Growth
4.6%
EPS
$0.42
Cooper Companies (The) Q4 FY2025 Financial Summary
Cooper Companies (The) reported revenue of $1.1B (up 4.6% YoY) for Q4 FY2025, with a net profit of $84.6M (down 28.0% YoY) (7.9% margin). Cost of goods sold was $414.3M, operating expenses totaled $510.4M.
Key Financial Metrics
| Total Revenue | $1.1B |
|---|---|
| Net Profit | $84.6M |
| Gross Margin | 61.1% |
| Operating Margin | 13.2% |
| Report Period | Q4 FY2025 |
Revenue Breakdown
Cooper Companies (The) Q4 FY2025 revenue of $1.1B breaks down across 4 segments, led by Sphere Other at $365.0M (34.3% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Sphere Other | $365.0M | 34.3% |
| Toric And Multifocal | $344.7M | 32.4% |
| Office And Surgical | $214.5M | 20.1% |
| Fertility | $140.9M | 13.2% |
Cooper Companies (The) Revenue by Segment — Quarterly Trend
Cooper Companies (The) revenue by segment across the last 4 reported quarters, showing how each business line (such as Sphere Other and Toric And Multifocal) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Sphere Other | $365.0M | $359.6M | $341.2M | — |
| Toric And Multifocal | $344.7M | $358.8M | $328.4M | — |
| Office And Surgical | $214.5M | $204.8M | $205.8M | $198.9M |
| Fertility | $140.9M | $137.1M | $126.9M | $119.7M |
Cooper Companies (The) Annual Revenue by Year
Cooper Companies (The) annual revenue history includes year-by-year totals (for example, 2025 revenue was $4.1B).
Cooper Companies (The) Quarterly Revenue & Net Profit History
Cooper Companies (The) results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $1.1B | +4.6% | $84.6M | 7.9% |
| Q3 FY2025 | $1.1B | +5.7% | $98.3M | 9.3% |
| Q2 FY2025 | $1.0B | +6.3% | $87.7M | 8.7% |
| Q1 FY2025 | $964.7M | +3.6% | $104.3M | 10.8% |
| Q4 FY2024 | $1.0B | +9.8% | $117.5M | 11.5% |
| Q3 FY2024 | $1.0B | +7.8% | $104.7M | 10.4% |
| Q2 FY2024 | $942.6M | +7.4% | $88.9M | 9.4% |
| Q1 FY2024 | $931.6M | +8.5% | $81.2M | 8.7% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $931.6M | $942.6M | $1.00B | $1.02B | $964.7M | $1.00B | $1.06B | $1.07B |
| YoY Growth | 8.5% | 7.4% | 7.8% | 9.8% | 3.6% | 6.3% | 5.7% | 4.6% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $12.03B | $12.05B | $12.11B | $12.32B | $12.22B | $12.41B | $12.38B | $12.39B |
| Liabilities | $4.34B | $4.24B | $4.18B | $4.23B | $4.09B | $4.13B | $4.02B | $4.16B |
| Equity | $7.70B | $7.80B | $7.92B | $8.08B | $8.13B | $8.29B | $8.35B | $8.24B |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $122.7M | $111.0M | $207.5M | $268.1M | $190.6M | $96.2M | $261.4M | $247.9M |